Dermata Therapeutics, Inc. (DRMA) Stock Analysis & Investment Frameworks

Dermata Therapeutics, Inc. (DRMA) stock analysis on Invetso. Review Dermata Therapeutics, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

Dermata Therapeutics, Inc. Company Overview

Dermata Therapeutics, Inc. Key Financial Metrics

About Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Dermata Therapeutics, Inc. Investment Frameworks

Invetso analyzes Dermata Therapeutics, Inc. (DRMA) across the following frameworks:

Explore More DRMA Research